Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Brazil health institute calls early reports on CoronaVac efficacy "mere speculation"

FILE PHOTO: A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter

The Brazilian public health institute handling trials for a COVID-19 vaccine developed by China's Sinovac Biotech said on Monday that any reports on the efficacy of the shot before a Dec. 23 announcement were "mere speculation."

The statement from the Butantan Institute, run by the Sao Paulo state government, followed a report in the Wall Street Journal that the efficacy rate for the so-called CoronaVac was higher than 50%, citing unnamed sources.

(Reporting by Pedro Fonseca; Writing by Marcelo Rochabrun; Editing by Brad Haynes)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.